Related references
Note: Only part of the references are listed.Atlas of type 2 dopamine receptors in the human brain: Age and sex dependent variability in a large PET cohort
Tuulia Malen et al.
NEUROIMAGE (2022)
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
Michelle Kokkinou et al.
MOLECULAR PSYCHIATRY (2021)
Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis
Ashley A. Conley et al.
PSYCHOPHARMACOLOGY (2021)
Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance
Stefan P. Brugger et al.
BIOLOGICAL PSYCHIATRY (2020)
Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging
Manon Dubol et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression
Hiroki Moriya et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Revisiting and expanding the meta-analysis of variation: The log coefficient of variation ratio
Alistair M. Senior et al.
RESEARCH SYNTHESIS METHODS (2020)
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials
Fredrik Hieronymus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies
Abhishekh H. Ashok et al.
PSYCHOPHARMACOLOGY (2019)
Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis
A. Tundo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence
Diego A. Pizzagalli et al.
JAMA PSYCHIATRY (2019)
Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Rebecca Strawbridge et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression
Jessie Muir et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant
Brendan D. Hare et al.
NATURE COMMUNICATIONS (2019)
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou et al.
MOLECULAR PSYCHIATRY (2018)
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [11C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study
Franklin R. Schneier et al.
BIOLOGICAL PSYCHIATRY (2018)
Translating the HAM-D into the MADRS and vice versa with equipercentile linking
Stefan Leucht et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study
Sabine Hellwig et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Meta-analysis and review of dopamine agonists in acute episodes of mood disorder: Efficacy and safety
Bruno Romeo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2018)
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation
J. Paul Hamilton et al.
TRANSLATIONAL PSYCHIATRY (2018)
Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response
Marta Pecina et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Dopamine System Dysregulation in Major Depressive Disorders
Pauline Belujon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia A Meta-analysis
Stefan P. Brugger et al.
JAMA PSYCHIATRY (2017)
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine A Systematic Review and Meta-analysis
Abhishekh H. Ashok et al.
JAMA PSYCHIATRY (2017)
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Sameer Jauhar et al.
JAMA PSYCHIATRY (2017)
Molecular imaging of striatal dopamine transporters in major depression-A meta-analysis
Zongchang Li et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression
Yun Kwok Wing et al.
NEUROLOGY (2015)
Amygdala-Ventral Pallidum Pathway Decreases Dopamine Activity After Chronic Mild Stress in Rats
Chun-hui Chang et al.
BIOLOGICAL PSYCHIATRY (2014)
Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies
Joseph Kambeitz et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-lodophenyl) tropane SPECT Study
Giovanni Camardese et al.
NEUROPSYCHOBIOLOGY (2014)
Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression
Bart P. de Kwaasteniet et al.
PLOS ONE (2014)
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder
Jonathan ' Savitz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Dipesh Chaudhury et al.
NATURE (2013)
The interaction between dopamine transporter function, gender differences, and possible laterality in depression
Mei-Chun Hsiao et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2013)
Dopamine agonist-responsive depression
Hiroaki Hori et al.
PSYCHOGERIATRICS (2013)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Greater striatal dopamine transporter density may be associated with major depressive episode
Jay D. Amsterdam et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Postpartum and Depression Status are Associated With Lower [11C]raclopride BPND in Reproductive-Age Women
Eydie L. Moses-Kolko et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews
Alison Booth et al.
SYSTEMATIC REVIEWS (2012)
Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program
Rongwei Fe et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
SPECT Imaging of Dopamine Transporters With 99mTc-TRODAT-1 in Major Depression and Parkinson's Disease
Hao Wu et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Electroconvulsive Therapy Decreases Dopamine D-2 Receptor Binding in the Anterior Cingulate in Patients With Depression: A Controlled Study Using Positron Emission Tomography With Radioligand [C-11]FLB 457
Tomoyuki Saijo et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study
Pei Chun Hsieh et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
Effect of a History of Major Depressive Disorder on Smoking-Induced Dopamine Release
Arthur L. Brody et al.
BIOLOGICAL PSYCHIATRY (2009)
Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112
Dara M. Cannon et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Dopaminergic Activity in Depressed Smokers: A Positron Emission Tomography Study
Usoa E. Busto et al.
SYNAPSE (2009)
Fluctuation scaling in complex systems: Taylor's law and beyond1
Zoltán Eisler et al.
ADVANCES IN PHYSICS (2008)
Midbrain serotonin and striatum dopamine transporter binding in double depression: A one-year follow-up study
Soili M. Lehto et al.
NEUROSCIENCE LETTERS (2008)
Temporal cortex dopamine D2/3 receptor binding in major depression
Soili M. Lehto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2008)
Greater availability of dopamine transporters in patients with major depression - A dual-isotope SPECT study
Yen Kuang Yang et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET
Jussi Hirvonen et al.
PSYCHOPHARMACOLOGY (2008)
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats
Christine Winter et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Extrastriatal D2 and striatal D2 receptors in depressive illness:: Pilot PET studies using [11C]FLB 457 and [11C]raclopride
Andrew J. Montgomery et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
The role of dopamine in the pathophysiology of depression
Boadie W. Dunlop et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Dopamine transporter binding in depressed patients with anhedonia
Marco Sarchiapone et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression
Yuko Kuroda et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Midbrain binding of [123I]nor-β-CIT in atypical depression
Soili Lehto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
The mesolimbic dopamine reward circuit in depression
Eric J. Nestler et al.
BIOLOGICAL PSYCHIATRY (2006)
Decreased striatal D1 binding as measured using PET and [C-11]SCH 23,390 in patients with major depression with anger attacks
Darin D. Dougherty et al.
DEPRESSION AND ANXIETY (2006)
Dopamine transporter availability in medication free and in bupropion treated depression:: A 99mTc-TRODAT-1 SPECT study
M Argyelán et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Smoking-induced ventral striatum dopamine release
AL Brody et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Greater availability of brain dopamine transporters in major depression shown by [99mTc]TRODAT-1 SPECT imaging
DJ Brunswick et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls:: a PET study
C Messa et al.
PSYCHOPHARMACOLOGY (2003)
Lower dopamine transporter binding potential in striatum during depression
JH Meyer et al.
NEUROREPORT (2001)
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
RV Parsey et al.
BIOLOGICAL PSYCHIATRY (2001)
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation
MLP Martinot et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers
J Lavalaye et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
M Laruelle
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Share Paper
